Active Ingredient History
Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Healthy Volunteers (Phase 3)
HIV (Phase 4)
HIV Infections (Phase 4)
Meningitis, Meningococcal (Phase 4)
Meningococcal Infections (Phase 3)
Meningococcal Vaccines (Phase 2)
Respiratory Syncytial Virus Infections (Phase 1)
Risk-Taking (Phase 3)
Splenectomy (Phase 3)
Unsafe Sex (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue